Bio-Techne (TECH) FY2022 results: revenue $1.1 billion, up 18.7% on the year
Bio-Techne Corp. (TECH) reported revenue of $1.1 billion for fiscal 2022, the year ended 30 June 2022, up 18.7% on the year before. Net income was $272 million, up 93.8%, and diluted earnings per share $1.66. The figures are the company's own, from the 10-K it filed with the SEC on 24 August 2022.
Revenue
$1.1 billion
+18.7% on the year
FY2015FY2022
Operating margin
26.8%
25.5% a year earlier
FY2015FY2022
Net income
$272 million
+93.8% on the year
FY2015FY2022
Diluted EPS
$1.66
+91.1% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
325
352
205
-7.6%
Capital expenditure
44.9
44.3
51.7
+1.4%
Free cash flow
280
308
153
-8.9%
Free cash flow margin
25.4%
33.1%
20.8%
Cash from investing
-96.9
-244
27.1
Cash from financing
-243
-62.6
-184
Depreciation and amortisation
101
87.7
82.7
+15.2%
Share-based compensation
42.2
49.0
32.4
-13.9%
Buybacks
161
43.2
50.1
+272.8%
Dividends paid
50.2
49.6
48.9
+1.1%
Dividend per share
$0.32
$0.32
$0.32
0.0%
Diluted shares, weighted
164m
162m
158m
+1.3%
Shares outstanding at period end
157m
156m
154m
+0.5%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
1,702
1,563
1,381
+8.9%
Non-controlling interest
-0.8
8.3
0.0
Debt
256
341
357
-25.0%
Operating lease liabilities
58.1
67.6
67.2
-14.0%
Other liabilities
280
283
222
-1.1%
Total liabilities and equity
2,295
2,263
2,028
+1.4%
Fixed assets
223
208
177
+7.4%
Goodwill
822
843
728
-2.5%
Intangible assets
532
616
517
-13.7%
Investments
74.5
32.5
124
+129.4%
Cash and equivalents
173
199
147
-13.3%
Receivables
195
145
123
+33.8%
Inventory
141
117
103
+20.9%
Other assets
135
102
109
+32.2%
Total assets
2,295
2,263
2,028
+1.4%
10-K for the year ended 30 June 2022, filed 24 August 2022: the filing.